Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Patti, Caterina
269  Ergebnisse:
Personensuche X
?
1

Real-World Outcome of Treatment with Single-Agent Ibrutinib..:

Mauro, Francesca Romana ; Scalzulli, Potito Rosario ; Scarfò, Lydia...
Cancers.  16 (2024)  6 - p. 1228 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Bendamustine and rituximab as first-line treatment for symp..:

Iannitto, Emilio ; Ferrero, Simone ; Bommier, Côme...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
3

Allogeneic Stem Cell Transplantation in Refractory Acute My..:

Bono, Roberto ; Sapienza, Giuseppe ; Tringali, Stefania...
Cells.  13 (2024)  9 - p. 755 , 2024
Link: https://doi.org/10.3390/..
 
?
4

A phase 2 study of the PI3Kδ inhibitor parsaclisib in relap..:

Phillips, Tycel J. ; Avigdor, Abraham ; Gurion, Ronit...
Blood Advances.  8 (2024)  4 - p. 867-877 , 2024
Link: https://doi.org/10.1182/..
 
?
5

Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory ..:

Zinzani, Pier Luigi ; Trněný, Marek ; Ribrag, Vincent...
eClinicalMedicine.  62 (2023)  - p. 102131 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Predictive value on advance hodgkin lymphoma treatment outc..:

Biggi, Alberto ; Chauvie, Stephane ; Fallanca, Federico...
Hematological Oncology.  41 (2023)  3 - p. 415-423 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Romidepsin-CHOEP followed by high-dose chemotherapy and ste..:

Chiappella, Annalisa ; Dodero, Anna ; Evangelista, Andrea...
Leukemia.  37 (2023)  2 - p. 433-440 , 2023
Link: https://doi.org/10.1038/..
 
?
8

Long-term follow-up of rituximab plus bendamustine and cyta..:

Tisi, Maria Chiara ; Moia, Riccardo ; Patti, Caterina...
Blood Advances.  7 (2023)  15 - p. 3916-3924 , 2023
Link: https://doi.org/10.1182/..
 
?
9

Correction: Bocci et al. Remarkable Remission Rate and Long..:

Bocci, Guido ; Pelliccia, Sabrina ; Orlandi, Paola...
Journal of Clinical Medicine.  12 (2023)  22 - p. 7053 , 2023
Link: https://doi.org/10.3390/..
 
?
10

A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of ac..:

Strati, Paolo ; Coleman, Morton ; Champion, Rebecca...
British Journal of Haematology.  199 (2022)  1 - p. 76-85 , 2022
Link: https://doi.org/10.1111/..
 
?
11

Real-world Outcomes of Relapsed/Refractory Diffuse Large B-..:

Argnani, Lisa ; Broccoli, Alessandro ; Pellegrini, Cinzia...
HemaSphere.  6 (2022)  12 - p. e798 , 2022
Link: https://doi.org/10.1097/..
 
?
12

T021: Radiation-Free Therapy as the INitial treatment of Go..:

Gallamini, Andrea ; Picardi, Marco ; Filonenko, Kateryna...
HemaSphere.  6 (2022)  - p. 10-11 , 2022
Link: https://doi.org/10.1097/..
 
?
13

The place of allogeneic stem cell transplantation in aggres..:

Castagna, Luca ; Bono, Roberto ; Tringali, Stefania...
Frontiers in Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
14

Treatment with Idelalisib in Patients with Relapsed or Refr..:

Casadei, Beatrice ; Argnani, Lisa ; Broccoli, Alessandro...
Cancers.  14 (2022)  3 - p. 654 , 2022
Link: https://doi.org/10.3390/..
 
?
15

P110: Outcome of high-dose chemotherapy (HDCT) and autologo..:

Viviani, Simonetta ; Vanazzi, Anna ; Frassoni, Samuele...
HemaSphere.  6 (2022)  - p. 51-51 , 2022
Link: https://doi.org/10.1097/..
 
1-15